Health care pharmaceutical companies by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 health care pharmaceutical companies ranked by one-year price change, at +395%, ahead of Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%). Figures as of 19 Nov 2026, 22:02 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+395%
- Median
- +27.0%
- Combined market value
- NOK 48.42T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +395% | NOK 48.7B | NOK 138.76 | 3.34% up | 395% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +332% | NOK 90.5B | NOK 952.67 | 3.77% down | 332% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +255% | NOK 64.6B | NOK 952.08 | 1.91% up | 255% up | ||
| 4 | VeradermicsMANE · Health Care | +231% | NOK 51.2B | NOK 1,213.79 | 0.38% down | 231% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +168% | NOK 39.4B | NOK 287.66 | 1.24% up | 168% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +129% | NOK 71.7B | NOK 912.71 | 1.59% down | 129% up | ||
| 7 | TG TherapeuticsTGTX · Health Care | +117% | NOK 95.7B | NOK 633.09 | 1.88% down | 117% up | ||
| 8 | Dianthus TherapeuticsDNTH · Health Care | +108% | NOK 46.6B | NOK 827.77 | 1.01% up | 108% up | ||
| 9 | ViatrisVTRS · Health Care | +99.0% | NOK 222.4B | NOK 193.99 | 1.97% down | 99% up | ||
| 10 | Roivant SciencesROIV · Health Care | +91.1% | NOK 275.5B | NOK 380.17 | 0.59% up | 91% up | ||
| 11 | Amneal PharmaceuticalsAMRX · Health Care | +90.0% | NOK 72.7B | NOK 208.72 | 2.24% down | 90% up | ||
| 12 | Praxis Precision MedicinesPRAX · Health Care | +86.0% | NOK 84.8B | NOK 3,033.74 | 1.87% up | 86% up | ||
| 13 | Edgewise TherapeuticsEWTX · Health Care | +85.9% | NOK 44B | NOK 401.73 | 0.48% down | 86% up | ||
| 14 | Royalty PharmaRPRX · Health Care | +78.9% | NOK 380B | NOK 660.81 | 1.38% down | 79% up | ||
| 15 | Teva Pharmaceutical IndustriesTEVA · Health Care | +73.9% | NOK 438.8B | NOK 376.07 | 8.74% down | 74% up | ||
| 16 | GenmabGMAB · Health Care | +69.7% | NOK 309B | NOK 501.07 | 0.75% up | 70% up | ||
| 17 | AlkermesALKS · Health Care | +66.2% | NOK 75.7B | NOK 450.62 | 1.43% down | 66% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +51.3% | NOK 667.5B | NOK 208.92 | 0.66% up | 51% up | ||
| 19 | Protagonist TherapeuticsPTGX · Health Care | +51.0% | NOK 79B | NOK 1,210.18 | 2.47% down | 51% up | ||
| 20 | Ligand PharmaceuticalsLGND · Health Care | +50.1% | NOK 56B | NOK 2,799.94 | 3.94% down | 50% up | ||
| 21 | Merck & CoMRK · Health Care | +45.1% | NOK 3.19T | NOK 1,295.95 | 3.61% down | 45% up | ||
| 22 | Travere TherapeuticsTVTX · Health Care | +44.7% | NOK 45.2B | NOK 471.31 | 3.86% down | 45% up | ||
| 23 | Belite BioBLTE · Health Care | +43.1% | NOK 59.9B | NOK 1,473.64 | 3.33% down | 43% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +41.0% | NOK 148.1B | NOK 2,307.26 | 4.57% down | 41% up | ||
| 25 | Johnson & JohnsonJNJ · Health Care | +34.3% | NOK 6.28T | NOK 2,606.73 | 2.04% down | 34% up | ||
| 26 | Mirum PharmaceuticalsMIRM · Health Care | +33.7% | NOK 60.8B | NOK 931.98 | 3.27% up | 34% up | ||
| 27 | Eli LillyLLY · Health Care | +32.5% | NOK 11.74T | NOK 13,184.13 | 2.29% down | 33% up | ||
| 28 | Bristol-Myers SquibbBMY · Health Care | +29.6% | NOK 1.16T | NOK 569.28 | 2.05% down | 30% up | ||
| 29 | Ascendis PharmaASND · Health Care | +29.0% | NOK 163.8B | NOK 2,497.64 | 5.32% down | 29% up | ||
| 30 | Regeneron PharmaceuticalsREGN · Health Care | +28.3% | NOK 932.1B | NOK 9,009.89 | 2.35% down | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +27.0% | NOK 1.29T | NOK 5,080.56 | 2.94% down | 27% up | ||
| 32 | Elanco Animal HealthELAN · Health Care | +25.7% | NOK 128.2B | NOK 256.54 | 1.54% down | 26% up | ||
| 33 | NovartisNVS · Health Care | +24.8% | NOK 2.79T | NOK 1,475.59 | 2.57% down | 25% up | ||
| 34 | AbbVieABBV · Health Care | +24.7% | NOK 4.89T | NOK 2,766.76 | 0.86% down | 25% up | ||
| 35 | United TherapeuticsUTHR · Health Care | +21.6% | NOK 232.3B | NOK 5,455.66 | 3.16% down | 22% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +20.7% | NOK 148.6B | NOK 762.87 | 0.22% up | 21% up | ||
| 37 | Rhythm PharmaceuticalsRYTM · Health Care | +18.3% | NOK 79B | NOK 1,139.73 | 1.88% down | 18% up | ||
| 38 | BioMarin PharmaceuticalBMRN · Health Care | +17.1% | NOK 116.1B | NOK 599.33 | 0.02% down | 17% up | ||
| 39 | BeOne MedicinesONC · Health Care | +15.5% | NOK 445.5B | NOK 3,900.24 | 0.97% down | 16% up | ||
| 40 | PfizerPFE · Health Care | +15.0% | NOK 1.53T | NOK 268.73 | 1.85% down | 15% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +13.2% | NOK 60.2B | NOK 425.93 | 1.25% up | 13% up | ||
| 42 | Dr. Reddy's LaboratoriesRDY · Health Care | +7.77% | NOK 120.6B | NOK 144.71 | 1.00% down | 8% up | ||
| 43 | GSKGSK · Health Care | +5.36% | NOK 935.3B | NOK 466.62 | 1.56% down | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +0.79% | NOK 2.65T | NOK 1,711.64 | 1.87% down | 1% up | ||
| 45 | GrifolsGRFS · Health Care | +0.47% | NOK 54.5B | NOK 80.02 | 3.19% down | 0% up | ||
| 46 | SanofiSNY · Health Care | -3.62% | NOK 1.08T | NOK 449.45 | 2.25% down | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -6.50% | NOK 69.6B | NOK 1,323.96 | 1.25% up | 6% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -9.67% | NOK 69.4B | NOK 634.07 | 4.15% down | 10% down | ||
| 49 | Abbott LaboratoriesABT · Health Care | -15.7% | NOK 1.76T | NOK 1,013.56 | 0.58% down | 16% down | ||
| 50 | Novo NordiskNVO · Health Care | -17.2% | NOK 1.67T | NOK 379.29 | 1.42% down | 17% down | ||
| 51 | CytokineticsCYTK · Health Care | -19.2% | NOK 70B | NOK 502.14 | 0.27% up | 19% down | ||
| 52 | Cogent BiosciencesCOGT · Health Care | -19.9% | NOK 47.1B | NOK 270.68 | 0.25% down | 20% down | ||
| 53 | PTC TherapeuticsPTCT · Health Care | -21.2% | NOK 47.5B | NOK 569.13 | 3.16% down | 21% down | ||
| 54 | ZoetisZTS · Health Care | -26.2% | NOK 320.3B | NOK 788.34 | 5.59% down | 26% down | ||
| 55 | Madrigal PharmaceuticalsMDGL · Health Care | -26.6% | NOK 89.9B | NOK 3,871.36 | 0.34% down | 27% down | ||
| 56 | ABIVAXABVX · Health Care | -31.8% | NOK 68.9B | NOK 786.98 | 3.79% down | 32% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -36.2% | NOK 82.5B | NOK 103.14 | 0.67% up | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.0% | NOK 309.2B | NOK 1,409.63 | 20.58% up | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -41.0% | NOK 30.5B | NOK 157.10 | 0.92% down | 41% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -62.5% | NOK 44.2B | NOK 265.61 | 0.62% down | 63% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.5% | NOK 193.2B | NOK 1,442.42 | 1.06% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7579 NOK).
Questions and answers
Which health care pharmaceutical companies rank first by one-year price change?
Erasca (+395%), Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%) are the top three of the 61 health care pharmaceutical companies ranked by one-year price change as of 19 Nov 2026, 22:02 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by one-year price change.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by one-year price change have a combined market value of NOK 48.42T as of 19 Nov 2026, 22:02 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care pharmaceutical companies by one-year price change”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.